Photo by impulsq from unsplash
To describe the treatment outcomes and recurrence risk of chronic central serous chorioretinopathy (cCSC) in patients who had complete resolution of subretinal fluid (SRF) after either primary half‐dose photodynamic therapy… Click to show full abstract
To describe the treatment outcomes and recurrence risk of chronic central serous chorioretinopathy (cCSC) in patients who had complete resolution of subretinal fluid (SRF) after either primary half‐dose photodynamic therapy (PDT) or high‐density subthreshold micropulse laser (HSML) in the PLACE trial.
Keywords:
chronic central;
photodynamic therapy;
treatment;
central serous;
serous chorioretinopathy;
micropulse laser
Journal Title: Acta Ophthalmologica
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Ophthalmologica
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!